๐ฌDeep Research
ADPT โ Adaptive Biotechnologies Corp ยท catalysts, narrative & risks
Adaptive Biotechnologies Corp. (ADPT) โ as of ~October 3, 2026
Below is a synthesis of the new sources, drawn on critically and cross-checked against each other. Note where aggregators conflict.
Market snapshot
ADPT closed at roughly $28.35 on October 2, 2026, with a market capitalization near $4.52 billion, ~159.6M shares outstanding, and a beta near 2.1 [11][20][22]. The stock is near its 52-week high of ~$29.96 (and has roughly doubled the market cap year-over-year, +104%) [14][20][24]. It is classified under Healthcare / Diagnostics & Research [22].
AI-assisted research from the K3vl4r desk โ not personalized investment advice. More research โ